Cytokines, CVSs, and the blood–brain-barrier. In: Ader, R,
Cohen, N, eds.
Psychoneuroimmunology, vol. 2. New York: Academic Press, 2001: 483–498.
The syntax of immune–neuroendocrine communication.
Immunol Today 1994;15: 504–511.
Aubert, Aet al. Cytokine actions on behavior. In: Rothwell, NJ, ed.
Cytokines and the Nervous System. London: Landes, 1996: 117–144.
Cytokines for psychologists. Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition.
Psychol Rev 1998;105: 83–107.
Long, WJ Jr,Sheld, WM.
Recombinant interleukin-1 induces meningitis and blood–brain barrier injury in the rat.
J Clin Invest 1991;87: 1360–1366.
The impact of stressors on immune and central transmitter activity: Bidirectional communication.
Rev Neurosci 1993;4: 147–180.
Neural circuits mediating stress.
Biol Psychiatry 1999;46: 461–471.
Allostasis and allostatic load. Implications for neuropsychopharmacology.
Neuropsychopharmacology 2000;22: 108–124.
The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies.
Biol Psychiatry 2001;49: 1023–1039.
Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity.
Brain Res Rev 1991;16: 223–244.
Transduction of psychosocial stress into the neurobiology of recurrent affective disorder.
Am J Psychiatry 1992;149: 999–1010.
Acute stress enhances while chronic stress suppresses skin immunity. The role of stress hormones and leukocyte trafficking.
Ann NY Acad Sci 2000;917: 876–893.
The neurobiology of stress: from serendipity to clinical relevance.
Brain Res 2000;886: 172–189.
Social disruption, immunity, and susceptibility to viral infection. Role of glucocorticoid insensitivity and NGF.
Ann NY Acad Sci 2000;917: 894–905.
16.de Groot, J,
Boersma, WJLong-term effects of social stress on antiviral immunity in pigs.
Physiol Behav 2001;73: 145–158.
Interleukin-1-induced plasticity of hypothalamic CRH neurons and long-term stress hyper-responsiveness.
Ann NY Acad Sci 1998;840: 65–73.
Cross-sensitization between immune and non-immune stressors. A role in the etiology of depression? Adv Exp Med Biol 1999;461: 179–197.
Differential activation of adrenal steroid receptors in neural and immune tissues of Sprague Dawley, Fischer 344, and Lewis rats.
J Neuroimmunol 1995;56: 77–90.
Influence of a psychogenic and a neurogenic stressor on several indices of immune functioning in different strains of mice.
Brain Behav Immun 1998;12: 7–22.
Health psychology. psychological factors and physical disease from the perspective of human psychoneuroimmunology.
Ann Rev Psychol 1996;47: 113–142.
Psychological stress and antibody response to immunization: a critical review of the human literature.
Psychosom Med 2001;63: 7–18.
Emotions, morbidity, and mortality: New perspectives from psychoneuroimmunology.
Ann Rev Psychol 2002;53: 83–107.
Associations between stress, trait negative affect, acute immune reactivity, and antibody response to hepatitis B injection in healthy young adults.
Health Psychol 2001;20: 4–11.
Acute psychological stressors and short-term immune changes: what, why, for whom, and to what extent? Psychosom Med 1992;54: 680–685.
Mucosal wound healing is impaired by examination stress.
Psychosom Med 1998;60: 362–365.
The influence of psychological stress on the immune response to vaccines.
Ann N Y Acad Sci 1998;840: 649–655.
Psychological stress, cytokine production, and severity of upper respiratory illness.
Psychosom Med 1999;61: 175–180.
Types of stressors that increase susceptibility to the common cold in healthy adults.
Health Psychol 1998;17: 214–223.
Van Bockstaele, DR,
Gastel, Aet al. The effects of psychological stress on leukocyte subset distribution in humans: evidence of immune activation.
Neuropsychobiology 1999;39: 1–9.
Lin, Aet al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety.
Cytokine 1998;10: 313–318.
Van Gastel, Aet al. Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations of natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes.
Psychiatr Res 1999;85: 293–303.
Chronic stress alters the immune response to influenza virus vaccine in older adults.
Proc Natl Acad Sci 1996;93: 3043–3047.
Kiecolt-Glaser, JKRecurrent syndromal depression in caregivers.
Psychol Aging 1995;10: 358–368.
Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes.
Gerontologist 1995;35: 771–791.
Spousal caregivers of dementia victims: longitudinal changes in immunity and health.
Psychosom Med 1991;53: 345–362.
Caregiving and the stress process: an overview of concepts and their measures.
Gerontologist 1990;30: 583–594.
Chronic stress in caregivers of dementia patients is associated with reduced lymphocyte sensitivity to glucocorticoids.
J Neuroimmunol 2000;103: 84–92.
Psychosocial modulation of cytokine-induced natural killer cell activity in older adults.
Psychosom Med 1996;58: 264–272.
Immunological consequences of acute and chronic stressors: mediating role of interpersonal relationships.
Br J Med Psychol 1988;61: 77–85.
Chronic stress modulates the immune response to a pneumococcal pneumonia vaccine.
Psychosom Med 2000;62: 804–807.
Chronic stress modulates the virus-specific immune response to latent herpes simplex virus type 1.
Ann Behav Med 1997;19: 78–82.
Wilcock, GKet al. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination.
Lancet 1999;353: 627–631.
Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress.
FASEB J 1991;5: 3100–3107.
Alzheimer caregiver stress. basal natural killer cell activity, pituitary-adrenal cortical function, and sympathetic tone.
Ann Behav Med 1997;19: 83–90.
The relationship between social support and physiological processes: a review with emphasis on underlying mechanisms and implications for health.
Psychol Bull 1996;119: 488–531.
The role of stressors and psychosocial variables in the stress process: a study of chronic caregiver stress.
Psychosom Med 2000;62: 374–385.
Hauger, RLet al. Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans.
Psychosom Med 1997;59: 447–457.
Poehlmann, KMet al. Autonomic and neuroendocrine responses to mild psychological stressors: effects of chronic stress on older women.
Ann Behav Med 2000;22: 140–148.
Linking the neuroendocrinology of post-traumatic stress disorder with recent neuroanatomic findings.
Sem Clin Neuropsychiatry 1999;4: 256–265.
Conflict between current knowledge about post-traumatic stress disorder and its original conceptual basis.
Am J Psychiatry 1995;152: 1705–1713.
Suppression of cellular immunity in men with a past history of post-traumatic stress disorder.
Am J Psychiatry 2001;158: 484–488.
Post-traumatic stress and lifestyles are associated with natural killer cell activity in victims of the Hanshin–Awaji earthquake in Japan.
Prev Med 2000;31: 467–473.
54.Everson, M P,
Blackburn, W D Jr.Stress and immune dysfunction in Gulf War veterans.
Ann NY Acad Sci 1999;876: 413–418.
Adler, Let al. Elevated cytotoxicity in combat veterans with long-term post-traumatic stress disorder: preliminary observations.
Brain Behav Immun 1998;12: 74–79.
56.Weiss, D W,
Tarcic, Net al. Studies in psychoneuroimmunology: psychological, immunological, and neuroendocrinological parameters in Israeli civilians during and after a period of Scud missile attacks.
Behav Med 1996;22: 5–14.
Rabatic, Set al. Immune, endocrine, and psychological responses in civilians displaced by war.
Psychosom Med 2000;62: 502–508.
Van Der Kolk, B,
Phenotype of blood lymphocytes in PTSD suggests chronic immune activation.
Psychosomatics 1999;40: 222–225.
Systems of coping associated with psychological distress: a profile perspective.
J Abn Psychol 2002 (in press).
Major depression and activation of the inflammatory response system.
Adv Exp Med Biol 1999;461: 25–46.
Evidence for an immune response in major depression. a review and hypothesis.
Progr Neuro-Psychopharmacol Biol Psychiatry 1995;19: 11–38.
Depression, hypothalamic–pituitary–adrenocortical activity, and lymphocyte function.
Psychopharmacol Bull 1985;21: 476–478.
Immune correlates of depression.
Adv Exp Med Biol 1999;461: 1–24.
Sleep and the immune system.
Int J Immunopharmacol 1995;17: 649–654.
Immunity and depression: Insomnia, retardation and reduction of natural killer cell activity.
J Behav Med 1994;17: 217–223.
Straus, SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
J Clin Endocrinol Metab 1991;148: 337–344.
Corticotropin releasing hormone in pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs.
Ann NY Acad Sci 1995;771: 716–729.
Brown, GMet al. Low plasma cortisol in bulimia nervosa patients with reversed neurovegetative symptoms of depression.
Biol Psychiatry 1997;41: 366–368.
Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features.
J Affect Disord 2000;58: 1–10.
Depression, adrenal steroids, and the immune system.
Ann Med 1993;25: 481–487.
Anhedonic and anxiogenic effects of cytokine exposure.
Adv Exp Med Biol 1999;461: 199–233.
72.Dunn, A J.
Interactions between the nervous system and the immune system. In: Bloom, FE,
Kupfer, DJ, eds.
Psychopharmacology: the Fourth Generation of Progress. New York: Raven Press, 1995: 719–731.
Effects of cytokines and infections on brain neurochemistry. In: Ader, R,
Cohen, N, eds.
Psychoneuroimmunology. New York: Academic Press, 2001: 649–666.
Central monoamine alterations associated with acute and repeated interleukin-2 administration.
Neuroimmunomodulation 2000;9: 1–16.
Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment.
Neuroscience 1999;88: 823–836.
The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection.
Mol Psychiatry 1999;4: 317–327.
77.van West, D,
Activation of the inflammatory response system: a new look at the etiopathogenesis of major depression.
Neuroendocrinol Lett 1999;20: 11–17.
Depression, stress and immunological activation: The role of cytokines in depressive disorders.
Life Sci 1998;62: 583–606.
Meltzer, HYet al. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic–pituitary–adrenal axis in severe depression.
Psychiatr Res 1993;49: 11–27.
Bosmans, Eet al. Evidence for a systemic immune activation during depression. Results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining.
Psychol Med 1992;22: 45–53.
Psychoneuroimmunology and the cytokine action in the CNS. implications for psychiatric disorders.
Prog Neuropsychopharm Biol Psychiatry 1998;22: 1–33.
The macrophage theory of depression.
Med Hypoth 1991;35: 298–306.
Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine.
Ann NY Acad Sci 1995;762: 474–476.
Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features.
Mol Psychiatry 1999;4: 182–188.
Interleukin-1 beta production in dysthymia before and after pharmacotherapy.
Biol Psychiatry 1999;46: 1649–1655.
Bosmans, Eet al. Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission.
Pol J Pharmacol 2000;52: 237–241.
Sensitization to the effects of tumor necrosis factor-α;neuroendocrine, central monoamine and behavioral variations.
J Neurosci 1999;19: 5654–5665.
Influence of interleukin-2 on responding for electrical brain stimulation from the hypothalamus.
Brain Res 1996;731: 1–11.
Pollak, Yet al. Cytokines, ‘depression due to a general medical condition’, and antidepressant drugs.
Adv Exp Med Biol 1999;461: 283–316.
Schuld, Aet al. Cytokine-associated emotional and cognitive disturbances in humans.
Arch Gen Psychiatry 2001;58: 445–452.
Puzella, Aet al. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system.
J Clin Psychopharmacol 2002;22: 86–90.
Marino, Vet al. Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms.
Psychiatr Res 2001;105: 45–55.
Gualde, Net al. Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy.
Psychoneuroendocrinology 2001;26: 797–808.
Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients.
Psychosom Med 2001;63: 376–386.
Belli, Fet al. Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration.
Eur J Cancer 1992;29A: 1266–1269.
Papa, MZet al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.
Ann Int Med 1987;107: 293–300.
Neurological and psychiatric adverse effects of immunological therapy.
CNS Drugs 1995;3: 56–68.
Depression from interferon therapy in patients with hepatitis C.
Am J Psychiatry 1999;156: 1120.
Ravaud, Aet al. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy.
Neuropsychopharmacology 2001;24: 130–140.
Gumnick, JFet al. Paroxetine for the prevention of the depression and neurotoxicity induced by high dose interferon alpha.
N Engl J Med 2001;344: 961–966.